Diseases, Conditions, Syndromes

Scientists find promising vaccine targets on hepatitis C virus

A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.

Medications

Study reveals potential of methotrexate to treat liver cancer

Liver cancer is one of the most prevalent and deadly types of cancer worldwide. Most patients are diagnosed at an advanced stage, which leaves them with few treatment options. Unfortunately, the first-line drugs used in advanced ...

Diseases, Conditions, Syndromes

Hepatitis C treatment's side effects can now be studied in the lab

(Medical Xpress)—The adverse side effects of certain hepatitis C medications can now be replicated and observed in Petri dishes and test tubes, thanks to a research team led by Craig Cameron, the Paul Berg Professor of ...

Diseases, Conditions, Syndromes

WHO monitors hepatitis of unknown origin in UK children

The World Health Organization said Friday it was monitoring cases of hepatitis of unknown origin in dozens of children in Britain, some of whom required a liver transplant.

Genetics

Gene variant increases fatty liver risk and fibrosis progression

New research confirms that a variant on the patatin-like phospholipase-3 (PNPLA3) gene increases risk of steatosis and fibrosis progression in patients with chronic hepatitis C virus (HCV). The PNPLA3 single nucleotide polymorphism ...

Oncology & Cancer

Hepatitis B viral load, surface antigen may ID liver cancer risk

(HealthDay)—Elevated levels of hepatitis B virus (HBV) DNA and hepatitis B surface antigen (HBsAg) are associated with increased risks of liver cancer, according to a study published online Oct. 24 in the Journal of Gastroenterology ...

page 13 from 40